42806-90-6

Basic information

• Product Name: 2-(4-Hydroxyphenoxy)-2-methylpropionic acid ethyl ester
• Synonyms: 2-(4-Hydroxyphenoxy)-2-methylpropionic acid ethyl ester;ethyl 2-(4-hydroxyphenoxy)-2-Methylpropanoate
• CAS NO: 42806-90-6
• Molecular Formula: C₁₂H₁₆O₄
• Molecular Weight: 224.25
• Mol File: 42806-90-6.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 335.1°C at 760 mmHg
• Flash Point: 123.8°C
• Appearance: /
• Density: 1.132g/cm³
• Vapor Pressure: 6.29E-05mmHg at 25°C
• Refractive Index: 1.515
• CAS DataBase Reference: 2-(4-Hydroxyphenoxy)-2-methylpropionic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-Hydroxyphenoxy)-2-methylpropionic acid ethyl ester(42806-90-6)
• EPA Substance Registry System: 2-(4-Hydroxyphenoxy)-2-methylpropionic acid ethyl ester(42806-90-6)

Safety Data

• Hazardous Substances Data: 42806-90-6(Hazardous Substances Data)

Usage

Appearance

White to off-white powder with a slight characteristic odor

Solubility

Soluble in most organic solvents

Uses

Production of pharmaceuticals, agrochemicals, and other specialty chemicals; intermediate in the synthesis of various pharmaceuticals and agrochemicals; potential as a corrosion inhibitor in certain applications

Importance

Versatile chemical compound with a wide range of applications in the synthesis of various products.

InChI:InChI=1/C12H16O4/c1-4-15-11(14)12(2,3)16-10-7-5-9(13)6-8-10/h5-8,13H,4H2,1-3H3

Upstream product

• 600-00-0 ethyl 2-bromoisobutyrate 
• 123-31-9 hydroquinone 
• 103-16-2 4-Benzyloxyphenol 
• 19587-96-3 ethyl 2-(4-(benzyloxy)phenoxy)-2-methylpropanoate 

Downstream Products

• 518343-90-3 2-[4-(2-bromoethoxy)-phenoxy]-2-methyl-propionic acid ethyl ester 
• 1214878-74-6 2-(4-{2-[2-(4-chloro-phenyl)-5,6-difluoro-benzoimidazol-1-yl]-2-cyclohexyl-ethoxy}-phenoxy)-2-methyl-propionic acid ethyl ester 
• 403611-83-6 2-Methyl-2-{4-[2-(2-phenyl-5-propyloxazol-4-yl)-ethoxy]phenoxy}propionic Acid Ethyl Ester 
• 328919-77-3 2-{4-[2-(2-biphenyl-3-yl-5-methyl-thiazol-4-yl)-ethoxy]-phenoxy}-2-methyl-propionic acid ethyl ester 
• 328918-90-7 2-(4-{2-[2-(4-bromophenyl)-5-methyloxazol-4-yl]ethoxy}phenoxy)-2-methylpropionic acid ethyl ester 
• 328919-79-5 2-(4-Dimethylthiocarbamoyloxy-phenoxy)-2-methyl-propionic acid ethyl ester 
• 860262-39-1 C₁₉H₂₈O₆ 
• 860262-10-8 C₁₅H₂₀O₆ 

Relevant articles and documents

PPARs-FXR multi-target micromolecular agonist as well as preparation method and application thereof

The invention discloses a PPARs-FXR multi-target micromolecule agonist and a preparation method and application thereof, the structure is shown in a general formula I, and the definition of each substituent group is shown in the description and claims. Th

Preparation and medical use for tetrahydroisoquinoline compound and salt of tetrahydroisoquinoline compound

The invention discloses a novel tetrahydroisoquinoline compound as well as a preparation method, a pharmaceutical composition and use thereof and particularly discloses a compound represented by a general formula (I) (shown in the description), a pharmaceutically acceptable salt of the compound, a preparation process of the compound, a pharmaceutical composition containing the compound representedby the general formula (I) and application of the compound and the composition in the treatment of diseases relevant with type 2 diabetes mellitus, hyperlipidemia and fatty liver.

1,2,4-Triazine Derivatives, Preparation and Use Thereof in Human Therapy

The invention concerns 3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives of general formula (I), wherein: R1 and R2, identical or different, represent a branched or linear C1-C7 alkyl or alkenyl radical, a C1/s